Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001199835-22-000832
Filing Date
2022-12-19
Accepted
2022-12-19 16:48:31
Documents
37
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 PEAK PHARMACEUTICALS, INC. 12/31/2021 10-Q pkph123121-10q.htm   iXBRL 10-Q 381933
2 CERTIFICATION pkph123121-ex31_1.htm EX-31.1 17976
3 CERTIFICATION pkph123121-ex31_2.htm EX-31.2 18076
4 CERTIFICATION pkph123121-ex32_1.htm EX-32.1 7291
5 CERTIFICATION pkph123121-ex32_2.htm EX-32.2 7320
  Complete submission text file 0001199835-22-000832.txt   1776829

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pkph-20211231.xsd EX-101.SCH 14666
7 XBRL CALCULATION FILE pkph-20211231_cal.xml EX-101.CAL 19688
8 XBRL DEFINITION FILE pkph-20211231_def.xml EX-101.DEF 42979
9 XBRL LABEL FILE pkph-20211231_lab.xml EX-101.LAB 124378
10 XBRL PRESENTATION FILE pkph-20211231_pre.xml EX-101.PRE 104321
31 EXTRACTED XBRL INSTANCE DOCUMENT pkph123121-10q_htm.xml XML 158188
Mailing Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260
Business Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260 480.659.6404
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

EIN.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-53855 | Film No.: 221471704
SIC: 2834 Pharmaceutical Preparations